PARP inhibition radiosensitizes BRCA1 wildtype and mutated breast cancer to proton therapy.
Ben Kacem M, Bright SJ, Moran E, Flint DB, Martinus DKJ, Turner BX, Qureshi I, Kolachina R, Manandhar M, Marinello PC, Shaitelman SF, Sawakuchi GO.
Ben Kacem M, et al. Among authors: qureshi i.
Sci Rep. 2024 Dec 28;14(1):30897. doi: 10.1038/s41598-024-81914-w.
Sci Rep. 2024.
PMID: 39730675
Free PMC article.